Furosemide (Page 4 of 4)

Geriatric Patients

In general, dose selection and dose adjustment for the elderly patient should be cautious, usually starting at the low end of the dosing range (see PRECAUTIONS: Geriatric Use).

HOW SUPPLIED:

Furosemide Tablets, USP are available as tablets for oral administration. Each tablet for oral administration contains 20 mg, 40 mg or 80 mg of furosemide, USP.

The 20 mg tablets are white, round, unscored tablets debossed with M2. They are available as follows:

NDC 51079-072-20 – Unit dose blister packages of 100 (10 cards of 10 tablets each).

The 40 mg tablets are white, round, scored tablets debossed with MYLAN over 216 on one side of the tablet and 40 on the other side. They are available as follows:

NDC 51079-073-20 – Unit dose blister packages of 100 (10 cards of 10 tablets each).

The 80 mg tablets are white, round, scored tablets debossed with MYLAN over 232 on one side of the tablet and 80 on the other side. They are available as follows:

NDC 51079-527-20 – Unit dose blister packages of 100 (10 cards of 10 tablets each).

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Protect from light.

Exposure to light may cause a slight discoloration. Discolored tablets should not be dispensed.

Manufactured by:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.

Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.

S-9628 R6
2/20

PRINCIPAL DISPLAY PANEL — 20 mg

NDC 51079-072-20

Furosemide
Tablets, USP
20 mg

100 Tablets (10 x 10)

Each tablet contains 20 mg of
furosemide, USP.

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from light.

Manufactured by:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Rx only

S-6407 R8

Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Furosemide 20 mg Tablets Unit Carton Label
(click image for full-size original)
Serialized Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 40 mg

NDC 51079-073-20

Furosemide
Tablets, USP
40 mg

100 Tablets (10 x 10)

Each tablet contains 40 mg of
furosemide, USP.

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from light.

Manufactured by:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Rx only

S-6410 R8

Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Furosemide 40 mg Tablets Unit Carton Label
(click image for full-size original)
Serialized Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 80 mg

NDC 51079-527-20

Furosemide
Tablets, USP
80 mg

100 Tablets (10 x 10)

Each tablet contains 80 mg of
furosemide, USP.

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from light.

Manufactured by:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Rx only

S-6405 R7

Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Furosemide 80 mg Tablets Unit Carton Label
(click image for full-size original)
Serialized Unit Carton
(click image for full-size original)
FUROSEMIDE furosemide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51079-072(NDC:0378-0208)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FUROSEMIDE (FUROSEMIDE) FUROSEMIDE 20 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
LACTOSE MONOHYDRATE
MICROCRYSTALLINE CELLULOSE
STARCH, CORN
STEARIC ACID
Product Characteristics
Color white Score no score
Shape ROUND Size 6mm
Flavor Imprint Code M2
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51079-072-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-072-01)
1 NDC:51079-072-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-072-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA018487 02/06/1997
FUROSEMIDE furosemide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51079-073(NDC:0378-0216)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FUROSEMIDE (FUROSEMIDE) FUROSEMIDE 40 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
LACTOSE MONOHYDRATE
MICROCRYSTALLINE CELLULOSE
STARCH, CORN
STEARIC ACID
Product Characteristics
Color white Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code MYLAN;216;40
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51079-073-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-073-01)
1 NDC:51079-073-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-073-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA018487 02/06/1997
FUROSEMIDE furosemide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51079-527(NDC:0378-0232)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FUROSEMIDE (FUROSEMIDE) FUROSEMIDE 80 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
LACTOSE MONOHYDRATE
MICROCRYSTALLINE CELLULOSE
STARCH, CORN
STEARIC ACID
Product Characteristics
Color white Score 2 pieces
Shape ROUND Size 10mm
Flavor Imprint Code MYLAN;232;80
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51079-527-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-527-01)
1 NDC:51079-527-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-527-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA070082 02/06/1997
Labeler — Mylan Institutional Inc. (039615992)

Revised: 05/2020 Mylan Institutional Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.